Clinical Trials Browser

Carcinoma, Neuroendocrine × avelumab × Endocrine × Clear all

NCT03352934 2022-02-25

AveNEC

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03278405 2020-03-18

NET-001

Phase 1/2 Completed

Carcinoma, Neuroendocrine

NCT03147404 2019-12-30

MS100070-0177

Phase 2 Completed

EndocrineLymphoid

Lymphoma, Follicular, Carcinoma, Neuroendocrine